FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds selected from a group comprising amides of peridine carboxylic acid of formula (I) , in which W denotes a phenyl ring or a six-member, non-benzocondensed aromatic ring, having one nitrogen atom, where said rings are substituted in the para-position through V; V denotes a bond; -A-(CH2)S- or -A-(CH2)v-B-; A and B independently denote -O-; U denotes mono-, di-, tri- or tetra-substituted aryl, in which substitutes are independently selected from a group consisting of halogen, alkyl and -CF3; Q denotes methylene; M denotes an aryl group, where the said group can be optionally mono- or di-substituted with substitutes independently selected from a group comprising alkyl; alkoxy; -CF3; halogen; alkyl-O-(CH2)0-4-CH2- and R'2N-(CH2)0-4-CH2-, where R' is independently selected from a group comprising hydrogen, alkyl (optionally substituted with one, two or three fluorine atoms), cyclopropyl, cyclopropylmethyl, -C(=O)-R", where R" denotes C1-C4-alkyl or -CH2-CF3; R1 denotes cycloalkyl; n equals 0 or 1; s equals 3; v equals 2; and substitutes in the ring, -CON(R1)-Q-M and -W-V-U, are in trans-position relative each other if n equals 1, and where configurations in positions 3 and 4 of the piperidine ring of formula (I) are 3R and 4R, respectively, if n equals 0; and optically pure enantiomers, mixture of enantiomers, such as racemates, diastereomers, mixture of diastereomers, diastereomer racemates, mixture of diastereomer racemates, and mesoforms, as well as to salts of such compounds. Invention also relates to a pharmaceutical composition.
EFFECT: obtaining novel biologically active compounds having non-peptide rennin inhibiting activity.
12 cl, 27 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
SECONDARY AMINES AS RENIN INHIBITORS | 2007 |
|
RU2425032C2 |
BRIDGED SPIRO[2,4]HEPTANE DERIVATIVES AS ALX AND/OR FPRL2 RECEPTOR AGONISTS | 2010 |
|
RU2540274C2 |
FLUORINATED AMINOTRIAZOLE DERIVATIVES | 2010 |
|
RU2544862C2 |
2-METHOXY-PYRIDIN-4-YL DERIVATIVES | 2012 |
|
RU2588141C2 |
PYRIDIN-2-YL DERIVATIVES AS IMMUNOMODULATORY AGENTS | 2009 |
|
RU2494099C2 |
PYRIDIN-3-YL DERIVATIVES AS IMMUNOMODULATORY AGENTS | 2007 |
|
RU2454413C2 |
OXAZOLYL-METHYLETHER DERIVATIVES AS ALX RECEPTOR AGONISTS | 2011 |
|
RU2588567C2 |
2-AZA-BICYCLO[3,3,0]OCTANE DERIVATIVES | 2008 |
|
RU2478099C2 |
1-[M-CARBOXAMIDO(HETERO)ARYL-METHYL]-HETEROCYCLYL-CARBOXAMIDE DERIVATIVES | 2013 |
|
RU2644761C2 |
DERIVATIVES OF 4-HYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE-1-YL-UREA AND THEIR USE IN TREATMENT, INTER ALIA, DISEASES OF RESPIRATORY TRACT | 2011 |
|
RU2586333C1 |
Authors
Dates
2011-01-27—Published
2006-05-23—Filed